All Stories

  1. Gut Microbiota in Metabolic Syndrome: Differences in Microbial Signatures and Clinical Profiles

    Article • Medicina, July 2026, MDPI AG

    Professor Ludovico Abenavoli

  2. Preliminary In Silico Evaluation of Extra Virgin Olive Oil-Derived Bioactive Compounds as Multi-Target-Directed Ligands in Metabolic Dysfunction-Associated Steatotic Liver Disease

    Article • Life, July 2026, MDPI AG

    Professor Ludovico Abenavoli

  3. Metabolic Dysfunction-Associated Steatotic Liver Disease and Incretin Receptor Agonists: A Metabolic Approach to Halting Liver Disease Progression

    Article • Medicina, May 2026, MDPI AG

    Professor Ludovico Abenavoli

  4. Immunonutrition for the Management of Postsurgery GI Cancer Patients

    Article • Nutrients, April 2026, MDPI AG

    Professor Ludovico Abenavoli

  5. Gastrointestinal Health: Clinical Research and Therapeutic Innovations

    Article • Life, March 2026, MDPI AG

    Professor Ludovico Abenavoli

  6. Bacteriophage Therapy Against Shigella spp.: A Precision Antimicrobial Strategy

    Article • Antibiotics, March 2026, MDPI AG

    Professor Ludovico Abenavoli

  7. Preoperative Carbohydrate Loading in Enhanced Recovery After Cesarean Protocols: Metabolic and Early Neonatal Outcomes

    Article • March 2026, MDPI AG

    Dr Alessandro Favilli, Professor Ludovico Abenavoli

  8. Preface

    Article • Reviews on Recent Clinical Trials, March 2026, Bentham Science Publishers

    Professor Ludovico Abenavoli

  9. The role of gut microbiota in the pathogenesis of primary biliary cholangitis: an immunological perspective

    Article • Expert Review of Clinical Immunology, January 2026, Taylor & Francis

    Professor Ludovico Abenavoli

  10. Annurca Apple Extract and Colorectal Cancer Prevention: Preliminary In Silico Evaluation of Chlorogenic Acid

    Article • Diseases, January 2026, MDPI AG

    Professor Ludovico Abenavoli

  11. Role of Liver Function in the Multiparametric Assessment of Hepatocellular Carcinoma

    Article • Medicina, January 2026, MDPI AG

    Professor Ludovico Abenavoli

  12. Metabolic Signatures of Breast Cancer Subtypes and the Metabolic Impact of Chemotherapy

    Article • Metabolites, January 2026, MDPI AG

    Professor Ludovico Abenavoli

  13. Gender, Age, Alpha-fetoprotein, and Des-gamma-carboxyprothrombin Score as a Novel Approach to Early Detection of Hepatocellular Carcinoma: A Narrative Review

    Article • Journal of Clinical and Experimental Hepatology, January 2026, Elsevier

    Professor Ludovico Abenavoli

  14. Guideline comparison for fatty liver disease: European (EASL-EASD-EASO) and Asian (APASL) perspectives

    Article • Expert Review of Gastroenterology & Hepatology, December 2025, Taylor & Francis

    Professor Ludovico Abenavoli

  15. Impact of Radiomic and Artificial Intelligence on Colorectal Cancer: A Narrative Review

    Article • Applied Sciences, December 2025, MDPI AG

    Professor Ludovico Abenavoli

  16. Gut Microbiota Changes in Metabolic Dysfunction-Associated Steatohepatitis and Inflammatory Bowel Disease: Common Pathogenic Features

    Article • Current Issues in Molecular Biology, October 2025, MDPI AG

    Professor Ludovico Abenavoli

  17. Metabolic Dysfunction-Associated Steatotic Liver Disease in a Patient with Phelan–McDermid Syndrome

    Article • Life, October 2025, MDPI AG

    Professor Ludovico Abenavoli

  18. Impact of Endoscopic Band Ligation on Gastric Complications Associated with Portal Hypertension

    Article • Gastroenterology Insights, August 2025, MDPI AG

    Professor Ludovico Abenavoli

  19. Whey Proteins and Metabolic Dysfunction-Associated Steatotic Liver Disease Features: Evolving the Current Knowledge and Future Trends

    Article • Metabolites, August 2025, MDPI AG

    Professor Ludovico Abenavoli

  20. Comment on Rotaru et al. Lean MASLD and IBD: Exploring the Intersection of Metabolic Dysfunction and the Gut–Liver Axis. Life 2025, 15, 288

    Article • Life, July 2025, MDPI AG

    Professor Ludovico Abenavoli

  21. Energy Requirements in the Post-ICU Period: An Exploratory Multicenter Observational Study

    Article • Nutrients, June 2025, MDPI AG

    Professor Ludovico Abenavoli

  22. Combined Model for the Diagnosis of Hepatocellular Carcinoma: A Pilot Study Comparing the Liver to Spleen Volume Ratio and Liver Vein to Cava Attenuation

    Article • Journal of Clinical Medicine, June 2025, MDPI AG

    Professor Ludovico Abenavoli

  23. Impact of Endoscopic Band Ligation on Gastric Complications Associated with Portal Hypertension

    Article • May 2025, MDPI AG

    Professor Ludovico Abenavoli

  24. Combined Model as a Predictor of Hepatocellular Carcinoma: A Pilot Study Comparing Liver Segmental Volume Ratio and Liver Vein to Cava Attenuation

    Article • May 2025, MDPI AG

    Professor Ludovico Abenavoli

  25. Unraveling the Metabolic Pathways Between Metabolic-Associated Fatty Liver Disease (MAFLD) and Sarcopenia

    Article • International Journal of Molecular Sciences, May 2025, MDPI AG

    Professor Ludovico Abenavoli, Dr. Rosa Direito

  26. Use of Metabolic Scores and Lipid Ratios to Predict Metabolic Dysfunction-Associated Steatotic Liver Disease Onset in Patients with Inflammatory Bowel Diseases

    Article • Journal of Clinical Medicine, April 2025, MDPI AG

    Professor Ludovico Abenavoli

  27. Editorial Board Members’ Collection Series: Gastrointestinal and Hepatic Diseases

    Article • Medicina, April 2025, MDPI AG

    Professor Ludovico Abenavoli

  28. The levels of inflammatory, angiogenic, and stress biomarkers in plasma of donors depending on anti-SARS-CoV-2 IgG titers

    Article • INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), April 2025, Publishing House Zaslavsky

    Professor Ludovico Abenavoli

  29. Preventive and Therapeutic Effects of Baicalein, Galangin, and Isorhamnetin in Chronic Liver Diseases: A Narrative Review

    Article • Molecules, March 2025, MDPI AG

    Professor Ludovico Abenavoli

  30. The Management of Cardiometabolic Risk in MAFLD: Therapeutic Strategies to Modulate Deranged Metabolism and Cholesterol Levels

    Article • Medicina, February 2025, MDPI AG

    Professor Ludovico Abenavoli

  31. Metabolic Dysfunction-Associated Steatotic Liver Disease vs. Metabolic Dysfunction-Associated Fatty Liver Disease: Which Option is the Better Choice?

    Article • British Journal of Hospital Medicine, February 2025, Mark Allen Group

    Professor Ludovico Abenavoli

  32. Gut microbiota: the pathogenetic bridge between inflammatory bowel disease and metabolic-associated steatotic liver disease

    Article • Expert Review of Gastroenterology & Hepatology, February 2025, Taylor & Francis

    Professor Ludovico Abenavoli

  33. Impact of Protein and Nutritional Support on the Muscular Status of Critically Ill Patients: A Pilot, Perspective, and Exploratory Study

    Article • Nutrients, January 2025, MDPI AG

    Professor Ludovico Abenavoli

  34. Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease

    Article • Antioxidants, November 2024, MDPI AG

    Professor Ludovico Abenavoli

  35. Use of Non-Invasive Biomarkers and Clinical Scores to Predict the Complications of Liver Cirrhosis: A Bicentric Experience

    Article • Medicina, November 2024, MDPI AG

    Professor Ludovico Abenavoli

  36. The anticancer activity of quercetin, luteolin, myricetin, and kaempferol in the development of hepatocellular carcinoma: a narrative review

    Article • Hepatoma Research, October 2024, OAE Publishing

    Professor Ludovico Abenavoli

  37. Metabolic-Associated Fatty Liver Disease: The Influence of Oxidative Stress, Inflammation, Mitochondrial Dysfunctions, and the Role of Polyphenols

    Article • Pharmaceuticals, October 2024, MDPI AG

    Professor Ludovico Abenavoli, Dr. Rosa Direito

  38. Unraveling Pneumomediastinum in COVID-19 Patients: Insights from a High-Volume-Center Case–Control Study

    Article • Diseases, October 2024, MDPI AG

    Professor Ludovico Abenavoli

  39. Sarcopenia and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review

    Article • Livers, September 2024, MDPI AG

    Professor Ludovico Abenavoli

  40. Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Inflammatory Bowel Diseases: A Pilot Study

    Article • Life, September 2024, MDPI AG

    Professor Ludovico Abenavoli

  41. The Diagnosis of Wilkie’s Syndrome Associated with Nutcracker Syndrome: A Case Report and Literature Review

    Article • Diagnostics, August 2024, MDPI AG

    Professor Ludovico Abenavoli

  42. Clostridioides difficile Infection: Use of Inflammatory Biomarkers and Hemogram-Derived Ratios to Predict Mortality Risk in Hospitalized Patients

    Article • Antibiotics, August 2024, MDPI AG

    Professor Ludovico Abenavoli

  43. Sarcopenia and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review

    Article • August 2024, MDPI AG

    Professor Ludovico Abenavoli

  44. Gut Microbiota, Deranged Immunity, and Hepatocellular Carcinoma

    Article • Biomedicines, August 2024, MDPI AG

    Dr Nazarii Kobyliak, Professor Ludovico Abenavoli

  45. Diagnosis of Wilkie’s Syndrome Associated with Nutcracker Syndrome: A Case Report and Literature Review

    Article • June 2024, MDPI AG

    Professor Ludovico Abenavoli

  46. International medical educational space in the context of digital civilization

    Article • Bioethics journal, May 2024, Volgograd State Medical University

    Professor Ludovico Abenavoli

  47. Impact of diet and gut microbiota changes in the development of hepatocellular carcinoma

    Article • Hepatoma Research, April 2024, OAE Publishing

    Professor Ludovico Abenavoli

  48. Onion Polyphenols as Multi-Target-Directed Ligands in MASLD: A Preliminary Molecular Docking Study

    Article • Nutrients, April 2024, MDPI AG

    Professor Ludovico Abenavoli

  49. Change in Diagnosis of Helicobacter pylori Infection in the Treatment-Failure Era

    Article • Antibiotics, April 2024, MDPI AG

    Professor Ludovico Abenavoli

  50. The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation

    Article • Medicina, March 2024, MDPI AG

    Professor Ludovico Abenavoli

  51. The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease

    Article • Diseases, March 2024, MDPI AG

    Professor Ludovico Abenavoli

  52. The COVID-19 Pandemic Is Over, but the Virus Still Lingers

    Article • Diseases, March 2024, MDPI AG

    Professor Ludovico Abenavoli

  53. The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation

    Article • March 2024, MDPI AG

    Professor Ludovico Abenavoli

  54. The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease

    Article • March 2024, MDPI AG

    Professor Ludovico Abenavoli

  55. Onion Polyphenols as Multi-Target-Directed Ligands in MASLD – a Preliminary Molecular Docking Study

    Article • February 2024, MDPI AG

    Professor Ludovico Abenavoli

  56. Post-Coronavirus Disease 2019 Pandemic Antimicrobial Resistance

    Article • Antibiotics, February 2024, MDPI AG

    Professor Ludovico Abenavoli

  57. Comment on Meneghini et al. The Impact of Nutritional Therapy in the Management of Overweight/Obese PCOS Patient Candidates for IVF. Nutrients 2023, 15, 4444

    Article • Nutrients, January 2024, MDPI AG

    Professor Ludovico Abenavoli

  58. Decoding MASLD’s Pathophysiology

    Article • January 2024, Springer Science + Business Media

    Professor Ludovico Abenavoli

  59. Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study

    Article • Medicina, November 2023, MDPI AG

    Professor Ludovico Abenavoli

  60. Effects of Origanum majorana on Breast Cancer Cells: An Alternative to Chemotherapy?

    Article • Metabolites, October 2023, MDPI AG

    Professor Ludovico Abenavoli

  61. Liver Damage and Impaired Coagulation in COVID-19 Patients: A Case Series

    Article • Diseases, October 2023, MDPI AG

    Professor Ludovico Abenavoli

  62. Impact of Immuno-Nutrition on the Nutritional Status, Inflammatory Response and Clinical Outcome of Clinic-Admitted Mild-Intensity-COVID-19 Patients: A Pilot, Perspective-Concluding Study

    Article • Metabolites, October 2023, MDPI AG

    Professor Ludovico Abenavoli

  63. Gut Microbiota and Critically Ill Patients: Immunity and Its Modulation via Probiotics and Immunonutrition

    Article • Nutrients, August 2023, MDPI AG

    Professor Ludovico Abenavoli

  64. Perspective on the Role of Gut Microbiome in the Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors

    Article • Medicina, August 2023, MDPI AG

    Professor Ludovico Abenavoli

  65. Comment on Clayton-Chubb et al. Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives. Nutrients 2023, 15, 687

    Article • Nutrients, June 2023, MDPI AG

    Professor Ludovico Abenavoli

  66. Gut Microbiota and Liver Transplantation: Immune Mechanisms behind the Rejection

    Article • Biomedicines, June 2023, MDPI AG

    Professor Ludovico Abenavoli

  67. Diagnosis of Liver Fibrosis Using Artificial Intelligence: A Systematic Review

    Article • Medicina, May 2023, MDPI AG

    Professor Ludovico Abenavoli

  68. Race: How the Post-Genomic Era Has Unmasked a Misconception Promoted by Healthcare

    Article • Medicina, April 2023, MDPI AG

    Professor Ludovico Abenavoli

  69. Case Report: A Migrating Stitch in a Crohn’s Disease Patient

    Article • The International Journal of Gastroenterology and Hepatology Diseases, April 2023, Bentham Science Publishers

    Professor Ludovico Abenavoli

  70. Liver Damage and COVID-19: At Least a “Two-Hit” Story in Systematic Review

    Article • Current Issues in Molecular Biology, April 2023, MDPI AG

    Professor Ludovico Abenavoli

  71. Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome

    Article • Medicina, March 2023, MDPI AG

    Professor Ludovico Abenavoli

  72. Effect of Immuno-Nutrition on Malnutrition, Inflammatory Response and Clinical Course of Semi-Critically Ill COVID-19 Patients: A Pilot Perspective Study

    Article • Nutrients, March 2023, MDPI AG

    Professor Ludovico Abenavoli

  73. The Use of Peppermint Oil in Gastroenterology

    Article • Current Pharmaceutical Design, March 2023, Bentham Science Publishers

    Professor Ludovico Abenavoli

  74. COVID-19: Where We Are and Where We Are Going

    Article • Diseases, March 2023, MDPI AG

    Professor Ludovico Abenavoli

  75. Decompressive Craniectomy in Severe Traumatic Brain Injury: The Intensivist’s Point of View

    Article • Diseases, January 2023, MDPI AG

    Professor Ludovico Abenavoli

  76. Recent Advances and Future Challenges in the Field of Digestive Diseases

    Article • Medicina, January 2023, MDPI AG

    Professor Ludovico Abenavoli

  77. Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay

    Article • Nutrients, December 2022, MDPI AG

    Professor Ludovico Abenavoli

  78. The Role of Autopsy and Post-Mortem Investigations in Falling Traumas in the Hospital Environment

    Article • Diagnostics, December 2022, MDPI AG

    Dr Angelo Lavano, Professor Ludovico Abenavoli

  79. Nutritional Support in Acute Liver Failure

    Article • Diseases, November 2022, MDPI AG

    Professor Ludovico Abenavoli

  80. Fecal Microbiota Transplantation in NAFLD Treatment

    Article • Medicina, October 2022, MDPI AG

    Professor Ludovico Abenavoli

  81. Alagille Syndrome and Its Clinical and Laboratory Features: A Case Report

    Article • Livers, October 2022, MDPI AG

    Professor Ludovico Abenavoli

  82. How Genetics and Genomics Advances Are Rewriting Pediatric Cancer Research and Clinical Care

    Article • Medicina, October 2022, MDPI AG

    Professor Ludovico Abenavoli

  83. Measuring Mood and Anxiety Disorders by Patient Reported Outcomes in Inflammatory Bowel Disease: A Literature Review Update

    Article • Reviews on Recent Clinical Trials, August 2022, Bentham Science Publishers

    Professor Ludovico Abenavoli

  84. The Legacy of Renato Dulbecco in the Post-Genomic Era

    Article • Medicina, July 2022, MDPI AG

    Professor Ludovico Abenavoli

  85. Farnesoid X Receptor, Bile Acid Metabolism, and Gut Microbiota

    Article • Metabolites, July 2022, MDPI AG

    Professor Ludovico Abenavoli

  86. Predicting the Spread of SARS-CoV-2 in Italian Regions: The Calabria Case Study, February 2020–March 2022

    Article • Diseases, June 2022, MDPI AG

    Professor Ludovico Abenavoli

  87. Mediterranean Diet: The Beneficial Effects of Lycopene in Non-Alcoholic Fatty Liver Disease

    Article • Journal of Clinical Medicine, June 2022, MDPI AG

    Professor Ludovico Abenavoli

  88. The Gut Microbiota Changes in Obese People: A New Perspective for the Modern Medicine

    Article • The International Journal of Gastroenterology and Hepatology Diseases, April 2022, Bentham Science Publishers

    Professor Ludovico Abenavoli

  89. Biological Mechanisms behind Wischnewsky Spots Finding on Gastric Mucosa: Autopsy Cases and Literature Review

    Article • International Journal of Environmental Research and Public Health, March 2022, MDPI AG

    Professor Ludovico Abenavoli

  90. Phenotypic Variability in Phelan–McDermid Syndrome and Its Putative Link to Environmental Factors

    Article • Genes, March 2022, MDPI AG

    Professor Ludovico Abenavoli

  91. Effect of Whey Proteins on Malnutrition and Extubating Time of Critically Ill COVID-19 Patients

    Article • Nutrients, January 2022, MDPI AG

    Professor Ludovico Abenavoli

  92. Current Status and Future Therapeutic Options for Fecal Microbiota Transplantation

    Article • Medicina, January 2022, MDPI AG

    Dr Nazarii Kobyliak, Professor Ludovico Abenavoli

  93. From Pre- and Probiotics to Post-Biotics: A Narrative Review

    Article • International Journal of Environmental Research and Public Health, December 2021, MDPI AG

    Professor Ludovico Abenavoli

  94. Изменения состава микробиоты кишечника, связанные с ожирением: новые результаты метагеномного анализа

    Article • INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), August 2021, Publishing House Zaslavsky

    Professor Ludovico Abenavoli, Dr Nazarii Kobyliak

  95. Probiotic Bacterial Application in Pediatric Critical Illness as Coadjuvants of Therapy

    Article • Medicina, July 2021, MDPI AG

    Professor Ludovico Abenavoli

  96. Effectiveness and Safety of A Nutraceutical Formulation for the Treatment of Functional Dyspepsia in Primary Care

    Article • Reviews on Recent Clinical Trials, July 2021, Bentham Science Publishers

    Prof. Antonio Tursi, Professor Ludovico Abenavoli, Antonio Pio Palieri, Federica Greco

  97. Intravenous Magnesium – Lidocaine - Ketorolac Cocktail for Postoperative Opioid Resistant Pain: A Case Series of Novel Rescue Therapy

    Article • Reviews on Recent Clinical Trials, July 2021, Bentham Science Publishers

    Professor Ludovico Abenavoli, Christian Zanza

  98. Management of Leaks Following Laparoscopic Sleeve Gastrectomy Using Specifically Designed Large Covered Metal Stents

    Article • Reviews on Recent Clinical Trials, July 2021, Bentham Science Publishers

    Professor Ludovico Abenavoli

  99. SARS-CoV-2 Spread Dynamics in Italy: The Calabria Experience

    Article • Reviews on Recent Clinical Trials, July 2021, Bentham Science Publishers

    Pietrantonio Ricci, Professor Ludovico Abenavoli, Christian Zanza

  100. Lock, Stock and Barrel: Role of Renin-Angiotensin-Aldosterone System in Coronavirus Disease 2019

    Article • Cells, July 2021, MDPI AG

    Professor Ludovico Abenavoli

  101. Nutritional Status and the Critically Ill Patient: Gut Microbiota and Immuno-Nutrition in I.C.U. at the Time of SARS-COV 2 Pandemic

    Article • Gastroenterology Insights, May 2021, MDPI AG

    Professor Ludovico Abenavoli

  102. Nutrigenomics and Nutrigenetics in Metabolic- (Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future Perspectives

    Article • Nutrients, May 2021, MDPI AG

    Professor Ludovico Abenavoli

  103. New Strategies for Clinical Trials in Autism Spectrum Disorder

    Article • Reviews on Recent Clinical Trials, May 2021, Bentham Science Publishers

    Professor Ludovico Abenavoli

  104. Anxiety and Gastrointestinal Symptoms Related to COVID-19 during Italian Lockdown

    Article • Journal of Clinical Medicine, March 2021, MDPI AG

    Professor Ludovico Abenavoli

  105. Resveratrol and other Stilbenes: Effects on Dysregulated Gene Expression in Cancers and Novel Delivery Systems

    Article • Anti-Cancer Agents in Medicinal Chemistry, February 2021, Bentham Science Publishers

    Prof. Baojun Xu, Professor Ludovico Abenavoli, palmiro poltronieri

  106. Metabolic Benefits of Probiotic Combination with Absorbent Smectite in type 2 Diabetes Patients a Randomised Controlled Trial

    Article • Reviews on Recent Clinical Trials, February 2021, Bentham Science Publishers

    Dr Nazarii Kobyliak, Professor Ludovico Abenavoli, Oleksandr Kovalchuk

  107. Preface

    Article • Reviews on Recent Clinical Trials, February 2021, Bentham Science Publishers

    Professor Ludovico Abenavoli

  108. The Plastic and Functional Changes in Hippocampal Neurons During Pregnancy, Delivery and Postpartum are Reversed by Offspring Deprivation

    Article • Current Psychopharmacologye, February 2021, Bentham Science Publishers

    Professor Ludovico Abenavoli

  109. Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease

    Article • Nutrients, February 2021, MDPI AG

    Professor Ludovico Abenavoli

  110. Risk Management and Treatment of Coagulation Disorders Related to COVID-19 Infection

    Article • International Journal of Environmental Research and Public Health, January 2021, MDPI AG

    Professor Ludovico Abenavoli

  111. Analysis of Nonsteroidal Anti-inflammatory Drugs by using Microfluidic Techniques: A Review

    Article • Current Pharmaceutical Analysis, January 2021, Bentham Science Publishers

    Thea Magrone, Professor Ludovico Abenavoli

  112. Anti-Toxoplasmic Immunoglobulin G Quantitation Correlates with Immunovirological Parameters of HIV-Infected Cameroonians

    Article • Current HIV Research, January 2021, Bentham Science Publishers

    Professor Ludovico Abenavoli, Dr Joseph Fokam, Yagai Bouba

  113. Mid-Aortic Syndrome: A Rare Cause of Renovascular Hypertension in Childhood Treated Percutaneously with an Unusual Vascular Access

    Article • Current Pediatric Reviews, January 2021, Bentham Science Publishers

    Professor Ludovico Abenavoli, VINCENZO TRIGGIANI

  114. Neonatal Hyperbilirubinemia: An Updated Appraisal of National Guidelines

    Article • Current Pediatric Reviews, January 2021, Bentham Science Publishers

    Professor Ludovico Abenavoli

  115. G-Protein Coupled Receptors Involved in the Resolution of Inflammation: Ligands and Therapeutic Perspectives

    Article • Mini-Reviews in Medicinal Chemistry, January 2021, Bentham Science Publishers

    Professor Ludovico Abenavoli, Marcello Leopoldo, Enza Lacivita

  116. Focus on Phytochemical and Pharmacological Profile of Prunus lycioides (=Amygdalus lycioides)

    Article • Mini-Reviews in Medicinal Chemistry, January 2021, Bentham Science Publishers

    Professor Ludovico Abenavoli

  117. Indications for Non-Invasive Ventilation in Respiratory Failure

    Article • Reviews on Recent Clinical Trials, January 2021, Bentham Science Publishers

    Thea Magrone, Professor Ludovico Abenavoli

  118. Management of Gastrointestinal Bleeding in Rendu-Osler Disease

    Article • Reviews on Recent Clinical Trials, January 2021, Bentham Science Publishers

    Thea Magrone, Professor Ludovico Abenavoli

  119. Liver Cirrhosis Complications Management at the Emergency Department

    Article • Reviews on Recent Clinical Trials, January 2021, Bentham Science Publishers

    Professor Ludovico Abenavoli, Dan Dumitrascu

  120. Disk Battery Ingestion: A Simple User-Guide

    Article • Reviews on Recent Clinical Trials, January 2021, Bentham Science Publishers

    Professor Ludovico Abenavoli

  121. Management of Immunotherapy Adverse Events in Oncological Patients: Anti-CTLA-4, Anti-PD-1/PD-L1

    Article • Reviews on Recent Clinical Trials, January 2021, Bentham Science Publishers

    Professor Ludovico Abenavoli, VINCENZO TRIGGIANI

  122. A Review on the Use of Reversal Agents of Direct Oral Anticogulant Drugs in Case of Gastrointestinal Bleeding

    Article • Reviews on Recent Clinical Trials, January 2021, Bentham Science Publishers

    Professor Ludovico Abenavoli, VINCENZO TRIGGIANI

  123. Management of Pleural Effusions in the Emergency Department

    Article • Reviews on Recent Clinical Trials, January 2021, Bentham Science Publishers

    Professor Ludovico Abenavoli, VINCENZO TRIGGIANI

  124. Clinical Management of Infectious Diarrhea

    Article • Reviews on Recent Clinical Trials, January 2021, Bentham Science Publishers

    Professor Ludovico Abenavoli, VINCENZO TRIGGIANI

  125. Honey Against Radiation-induced Oral Mucositis in Head and Neck Cancer Patients. An Umbrella Review of Systematic Reviews and Meta- Analyses of the Literature

    Article • Reviews on Recent Clinical Trials, January 2021, Bentham Science Publishers

    ARETI GKANTAIFI, Elias Papadopoulos, Nikolaos Tsoukalas, Professor Ludovico Abenavoli

  126. An Approach to Diabetic Ketoacidosis in an Emergency Setting

    Article • Reviews on Recent Clinical Trials, January 2021, Bentham Science Publishers

    Professor Ludovico Abenavoli, VINCENZO TRIGGIANI

  127. Bedside Cardiac Pocus in Emergency Setting: A Practice Review

    Article • Reviews on Recent Clinical Trials, January 2021, Bentham Science Publishers

    Professor Ludovico Abenavoli

  128. Gut Alterations in Septic Patients: A Biochemical Literature Review

    Article • Reviews on Recent Clinical Trials, January 2021, Bentham Science Publishers

    Professor Ludovico Abenavoli

  129. New Paradigms to Help Decisions in Treatment Choice: Head to Head Trial of Biological Therapies in Inflammatory Bowel Diseases

    Article • Current Drug Targets, December 2020, Bentham Science Publishers

    Professor Ludovico Abenavoli, VINCENZO TRIGGIANI

  130. The Role of Targeted HIV Screening in the Emergency Department: A Scoping Review

    Article • Current HIV Research, November 2020, Bentham Science Publishers

    Professor Ludovico Abenavoli, Dr Nazir I Lone

  131. Application of Ultrasound Elastography for Assessing Intestinal Fibrosis in Inflammatory Bowel Disease: Fiction or Reality?

    Article • Current Drug Targets, November 2020, Bentham Science Publishers

    Professor Ludovico Abenavoli

  132. Potential Anticancer Effect of Carvacrol Codrugs on Human Glioblastoma Cells

    Article • Current Drug Delivery, October 2020, Bentham Science Publishers

    Professor Ludovico Abenavoli, Dr. Ayşenur Yazıcı

  133. Fibrotic Strictures in Crohn’s Disease: Mechanisms and Predictive Factors

    Article • Current Drug Targets, October 2020, Bentham Science Publishers

    Professor Ludovico Abenavoli, Mohammad Khaled Shalaby, Mohammad Khaled Shalaby

  134. COVID-19: a Great Mime or a Trigger Event of Autoimmune Manifestations?

    Article • Current Rheumatology Reviews, October 2020, Bentham Science Publishers

    Professor Ludovico Abenavoli

  135. Venous Thrombo-Embolism in Hospitalized SARS-CoV-2 Patients Treated with Three Different Anticoagulation Protocols: Prospective Observational Study

    Article • Biology, September 2020, MDPI AG

    Professor Ludovico Abenavoli

  136. Prevention of COVID-19 Infection in the Medical Population: Possible Help from Anosmia?

    Article • Reviews on Recent Clinical Trials, September 2020, Bentham Science Publishers

    Professor Ludovico Abenavoli

  137. Light Alcohol Drinking and the Risk of Cancer Development: A Controversial Relationship

    Article • Reviews on Recent Clinical Trials, September 2020, Bentham Science Publishers

    Professor Ludovico Abenavoli

  138. Tocilizumab in Sars-cov-2 Patients with the Syndrome of Cytokine Storm; a Narrative review

    Article • Reviews on Recent Clinical Trials, September 2020, Bentham Science Publishers

    Dr. Vitalii B. Kaliberdenko, Dr. Shanmugaraj Kulanthaivel, Professor Ludovico Abenavoli

  139. Dealing with COVID-19: lessons learned from the Italian experience

    Article • Coronaviruses, September 2020, Bentham Science Publishers

    Professor Ludovico Abenavoli, GIOVANNI BOCCIA, Dr Silvana Mirella Aliberti

  140. COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center Survey

    Article • Medicina, August 2020, MDPI AG

    Professor Ludovico Abenavoli

  141. Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic

    Article • Journal of Clinical Medicine, August 2020, MDPI AG

    Professor Ludovico Abenavoli

  142. The role of the COVID-19 pandemic as a risk factor for suicide: What is its impact on the public mental health state today?

    Article • Psychological Trauma Theory Research Practice and Policy, August 2020, American Psychological Association (APA)

    Professor Ludovico Abenavoli

  143. The Deadly Quartet (Covid-19, old age, lung disease, and heart failure) explain why coronavirus-related mortality in northern Italy was so high

    Article • Current Cardiology Reviews, July 2020, Bentham Science Publishers

    giuseppe calcaterra, Professor Ludovico Abenavoli, VINCENZO TRIGGIANI, Dr Pier Paolo Bassareo

  144. Electrophysiological and Clinical Improvement in Non-Invasive Treatment of Carpal Tunnel Syndrome

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, July 2020, Bentham Science Publishers

    Professor Ludovico Abenavoli, Professor Marisa Megna, VINCENZO TRIGGIANI

  145. The Reality of Patient-Reported Outcomes of Health-Related Quality of Life in an Italian Cohort of Patients with Inflammatory Bowel Disease: Results from a Cross-Sectional Study

    Article • Journal of Clinical Medicine, July 2020, MDPI AG

    Professor Ludovico Abenavoli

  146. Smart Nanocarriers for Targeted Cancer Therapy

    Article • Anti-Cancer Agents in Medicinal Chemistry, June 2020, Bentham Science Publishers

    Professor Ludovico Abenavoli, Chiara Martinelli

  147. Primary Biliary Cholangitis and Bile Acid Farnesoid X Receptor Agonists

    Article • Diseases, June 2020, MDPI AG

    Professor Ludovico Abenavoli

  148. Circadian rhythms of endothelial nitric oxide synthase and toll-like receptors 2 production in females with rheumatoid arthritis depending on NOS3 gene polymorphism

    Article • Reviews on Recent Clinical Trials, April 2020, Bentham Science Publishers

    Professor Ludovico Abenavoli, Oleksandr Maievskyi, Kateryna Zaichko , Prof MYKOLA STANISLAVCHUK

  149. Alcohol associated liver disease 2020: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF)

    Article • Digestive and Liver Disease, April 2020, Elsevier

    Professor Ludovico Abenavoli

  150. Barriers And Facilitators In Conducting Clinical Trials In Inflammatory Bowel Disease: A Monocentric Italian Survey

    Article • Reviews on Recent Clinical Trials, February 2020, Bentham Science Publishers

    Professor Ludovico Abenavoli

  151. Preface

    Article • Reviews on Recent Clinical Trials, February 2020, Bentham Science Publishers

    Professor Ludovico Abenavoli

  152. Gut Microbiota and Obesity: A Role for Probiotics

    Article • Nutrients, November 2019, MDPI AG

    Dr Javad Sharifi Rad, Carmela Colica, Professor Ludovico Abenavoli

  153. High Flow Through Nasal Cannula in Stable and Exacerbated Chronic Obstructive Pulmonary Disease Patients

    Article • Reviews on Recent Clinical Trials, November 2019, Bentham Science Publishers

    Professor Ludovico Abenavoli

  154. The Skin in Celiac Disease Patients: The Other Side of the Coin

    Article • Medicina, September 2019, MDPI AG

    Professor Ludovico Abenavoli

  155. Chemical Effect of Bisphenol A on Non-Alcoholic Fatty Liver Disease

    Article • International Journal of Environmental Research and Public Health, August 2019, MDPI AG

    Professor Ludovico Abenavoli

  156. Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way

    Article • International Journal of Environmental Research and Public Health, August 2019, MDPI AG

    Professor Ludovico Abenavoli

  157. Self-Prescribed Dietary Restrictions are Common in Inflammatory Bowel Disease Patients and Are Associated with Low Bone Mineralization

    Article • Medicina, August 2019, MDPI AG

    Professor Ludovico Abenavoli

  158. A Hazelnut-Enriched Diet Modulates Oxidative Stress and Inflammation Gene Expression without Weight Gain

    Article • Oxidative Medicine and Cellular Longevity, July 2019, Hindawi Publishing Corporation

    Professor Ludovico Abenavoli, marco marchetti

  159. Olive oil antioxidants and non-alcoholic fatty liver disease

    Article • Expert Review of Gastroenterology & Hepatology, June 2019, Taylor & Francis

    Professor Ludovico Abenavoli

  160. Lamium Plants—A Comprehensive Review on Health Benefits and Biological Activities

    Article • Molecules, May 2019, MDPI AG

    Dr Javad Sharifi Rad, Professor Ludovico Abenavoli

  161. Use of Complementary and Alternative Medicine by Patients with Irritable Bowel Syndrome According to the Roma IV Criteria: A Single-Center Italian Survey

    Article • Medicina, February 2019, MDPI AG

    Professor Ludovico Abenavoli

  162. Effect of Chondroitin Sulfate on Blood Serum Cytokine Profile during Carrageenan-induced Edema and Monoiodoacetate-induced Osteoarthritis in Rats

    Article • Reviews on Recent Clinical Trials, January 2019, Bentham Science Publishers

    Professor Ludovico Abenavoli, Andrii Vovk

  163. Preface

    Article • Reviews on Recent Clinical Trials, January 2019, Bentham Science Publishers

    Professor Ludovico Abenavoli

  164. Obeticholic Acid: A New Era in the Treatment of Nonalcoholic Fatty Liver Disease

    Article • Pharmaceuticals, October 2018, MDPI AG

    Dr Nazarii Kobyliak, Professor Ludovico Abenavoli

  165. Rosmarinic Acid as Potential Anti-Inflammatory Agent

    Article • Reviews on Recent Clinical Trials, October 2018, Bentham Science Publishers

    Professor Ludovico Abenavoli, Carmela Colica

  166. A Systematic Review on Natural Antioxidant Properties of Resveratrol

    Article • Natural Product Communications, September 2018, SAGE Publications

    Professor Ludovico Abenavoli, Carmela Colica

  167. Milk thistle (Silybum marianum ): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases

    Article • Phytotherapy Research, August 2018, Wiley

    Professor Ludovico Abenavoli, Dr Raffaele Capasso

  168. Basics in Endoscopic Ultrasound Part 2: EUS-guided Sampling and Therapeutic Applications

    Article • Reviews on Recent Clinical Trials, May 2018, Bentham Science Publishers

    Professor Ludovico Abenavoli

  169. Resistin levels in non-alcoholic fatty liver disease pathogenesis

    Article • Journal of Translational Internal Medicine, March 2018, De Gruyter

    Professor Ludovico Abenavoli, Carmela Colica

  170. Serum Complement C3 and Type 2 Diabetes in Rheumatoid Arthritis: a Case-Control Study

    Article • Reviews on Recent Clinical Trials, March 2018, Bentham Science Publishers

    Professor Ludovico Abenavoli, Professor Giovambattista De Sarro

  171. Basics in Endoscopic Ultrasound Part 1: Diagnostic Indications and Tissue Sampling

    Article • Reviews on Recent Clinical Trials, January 2018, Bentham Science Publishers

    Professor Ludovico Abenavoli

  172. The Emerging Role of Complement C3 as A Biomarker of Insulin Resistance and Cardiometabolic Diseases: Preclinical and Clinical Evidence

    Article • Reviews on Recent Clinical Trials, January 2018, Bentham Science Publishers

    Professor Ludovico Abenavoli

  173. Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study

    Article • Nutrients, August 2017, MDPI AG

    Professor Ludovico Abenavoli

  174. Gut microbiota changes and chronic hepatitis C virus infection

    Article • Expert Review of Gastroenterology & Hepatology, June 2017, Taylor & Francis

    Professor Ludovico Abenavoli

  175. Adiponectin serum level changes and its dynamic relationship with hepatitis C during viral clearance

    Article • Virulence, April 2017, Taylor & Francis

    Professor Ludovico Abenavoli

  176. Polyphenols treatment in patients with nonalcoholic fatty liver disease

    Article • Journal of Translational Internal Medicine, January 2017, De Gruyter

    Professor Ludovico Abenavoli

  177. The influence of phthalates and bisphenol A on the obesity development and glucose metabolism disorders

    Article • Endocrine, November 2016, Springer Science + Business Media

    Professor Ludovico Abenavoli

  178. Editorial (Thematic Issue: Alcoholic Liver Disease: From Bench to Bedside)

    Article • Reviews on Recent Clinical Trials, August 2016, Bentham Science Publishers

    Professor Ludovico Abenavoli

  179. Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence

    Article • Journal of Hepatology, December 2015, Elsevier

    Professor Ludovico Abenavoli

  180. Non-alcoholic fatty liver disease severity, central fat mass and adinopectin: a close relationship

    Article • Clujul Medical, November 2015, Clujul Medical

    Professor Ludovico Abenavoli

  181. Estimation of in vivo and in vitro exposure to bisphenol A as food contaminant

    Article • Food and Chemical Toxicology, September 2015, Elsevier

    Professor Ludovico Abenavoli, Prof. Dr Dragana D Četojević-Simin

  182. Meet Our Editorial Board Member:

    Article • Reviews on Recent Clinical Trials, May 2015, Bentham Science Publishers

    Professor Ludovico Abenavoli

  183. Risk factors for accelerated atherosclerosis in young women with hyperprolactinemia

    Article • Medical Hypotheses, April 2015, Elsevier

    Professor Ludovico Abenavoli

  184. The Role of Liver Biopsy to Assess Non-Alcoholic Fatty Liver Disease

    Article • Reviews on Recent Clinical Trials, January 2015, Bentham Science Publishers

    Professor Ludovico Abenavoli, Dr Nazarii Kobyliak

  185. Role of Adipokines and Cytokines in Non-alcoholic Fatty Liver Disease

    Article • Reviews on Recent Clinical Trials, January 2015, Bentham Science Publishers

    Professor Ludovico Abenavoli

  186. Phytotherapy and NAFLD - from Goals and Challenges to Clinical Practice

    Article • Reviews on Recent Clinical Trials, January 2015, Bentham Science Publishers

    Professor Ludovico Abenavoli

  187. Non Alcoholic Fatty Liver: Epidemiology and Natural History

    Article • Reviews on Recent Clinical Trials, January 2015, Bentham Science Publishers

    Professor Ludovico Abenavoli

  188. non-alcoholic fatty liver disease

    Article • Reviews on Recent Clinical Trials, January 2015, Bentham Science Publishers

    Professor Ludovico Abenavoli

  189. Effects of Mediterranean diet supplemented with silybin–vitamin E–phospholipid complex in overweight patients with non-alcoholic fatty liver disease

    Article • Expert Review of Gastroenterology & Hepatology, January 2015, Taylor & Francis

    Professor Ludovico Abenavoli

  190. Non-alcoholic fatty liver disease and beneficial effects of dietary supplements

    Article • World Journal of Hepatology, January 2015, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Ludovico Abenavoli

  191. Adiponectin serum level in chronic hepatitis C infection and therapeutic profile

    Article • World Journal of Hepatology, January 2015, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Ludovico Abenavoli

  192. C677T gene polymorphism of MTHFR and metabolic syndrome: response to dietary intervention

    Article • Journal of Translational Medicine, November 2014, Springer Science + Business Media

    Professor Ludovico Abenavoli

  193. Enhanced Expression of Indoleamine 2,3-Dioxygenase inHelicobacter pylori-Infected Human Gastric Mucosa Modulates Th1/Th2 Pathway and Interleukin 17 Production

    Article • Helicobacter, October 2014, Wiley

    Professor Ludovico Abenavoli

  194. Su1939 Enhanced Expression of Indoleamine 2,3-Dioxygenase (IDO) in Helicobacter pylori-Infected Human Gastric Mucosa Modulates TH1/Th2 Pathway and Interleukin (IL)-17 Production

    Article • Gastroenterology, May 2014, Elsevier

    Professor Ludovico Abenavoli

  195. 1028 High Exposure, Spontaneous Clearance and Low Incidence of Active Helicobacter pylori Infection: The Sorbo San Basile Study

    Article • Gastroenterology, May 2014, Elsevier

    Professor Ludovico Abenavoli

  196. Metformin in the treatment of non-alcoholic fatty liver disease: safety, efficacy and mechanism

    Article • Expert Review of Gastroenterology & Hepatology, March 2014, Taylor & Francis

    Professor Ludovico Abenavoli

  197. Pharmacotherapy of acute alcoholic hepatitis in clinical practice

    Article • World Journal of Gastroenterology, January 2014, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Ludovico Abenavoli

  198. Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet

    Article • World Journal of Gastroenterology, January 2014, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Ludovico Abenavoli

  199. Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3

    Article • World Journal of Gastroenterology, January 2014, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Ludovico Abenavoli, Dr Nazarii Kobyliak

  200. Prevalence of Peripheral Artery Disease by Abnormal Ankle-Brachial Index in Atrial Fibrillation

    Article • Journal of the American College of Cardiology, December 2013, Elsevier

    Professor Ludovico Abenavoli, Dr Marco Proietti

  201. Association between non-alcoholic fatty liver disease, insulin resistance and Helicobacter pylori

    Article • Medical Hypotheses, November 2013, Elsevier

    Professor Ludovico Abenavoli

  202. Milk thistle to treat non-alcoholic fatty liver disease: dream or reality?

    Article • Expert Review of Gastroenterology & Hepatology, November 2013, Taylor & Francis

    Professor Ludovico Abenavoli

  203. Type 2 diabetes mellitus in chronic hepatitis C virus infection: risk factor or consequence?

    Article • Expert Review of Gastroenterology & Hepatology, May 2013, Taylor & Francis

    Professor Ludovico Abenavoli

  204. Liver Transplantation in Alcoholic Patients: Impact of an Alcohol Addiction Unit Within a Liver Transplant Center

    Article • Alcoholism Clinical and Experimental Research, April 2013, Wiley

    Professor Ludovico Abenavoli

  205. Dietary Intervention in Non-Alcoholic Fatty Liver Disease

    Article • Journal of the Academy of Nutrition and Dietetics, February 2013, Elsevier

    Professor Ludovico Abenavoli

  206. Pharmacovigilance and drug safety in Calabria (Italy): 2012 adverse events analysis

    Article • Journal of Pharmacology and Pharmacotherapeutics, January 2013, Medknow

    Professor Ludovico Abenavoli

  207. Hepatitis C virus genotypes in north eastern Algeria: A retrospective study

    Article • World Journal of Hepatology, January 2013, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Ludovico Abenavoli

  208. A pathogenetic link between non-alcoholic fatty liver disease and celiac disease

    Article • Endocrine, June 2012, Springer Science + Business Media

    Professor Ludovico Abenavoli

  209. Anti-oxidant therapy in non-alcoholic fatty liver disease: the role of silymarin

    Article • Endocrine, April 2012, Springer Science + Business Media

    Professor Ludovico Abenavoli

  210. Helicobacter species and liver disease

    Article • Journal of Gastroenterology, April 2012, Springer Science + Business Media

    Professor Ludovico Abenavoli

  211. High prevalence of polymorphism and low activity of thiopurine methyltransferase in patients with inflammatory bowel disease

    Article • European Journal of Internal Medicine, April 2012, Elsevier

    Professor Ludovico Abenavoli

  212. Il danno epatico da farmaci

    Article • Recenti Progressi in Medicina, February 2012, Il Pensiero Scientifico Editore

    Professor Ludovico Abenavoli

  213. Bone Mineralization in Celiac Disease

    Article • Gastroenterology Research and Practice, January 2012, Hindawi Publishing Corporation

    Professor Ludovico Abenavoli

  214. No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease

    Article • World Journal of Gastroenterology, January 2012, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Ludovico Abenavoli

  215. Adiponectin levels in nonalcoholic fatty liver disease

    Article • Metabolism, December 2011, Elsevier

    Professor Ludovico Abenavoli

  216. Transient Elastography for Assessment of Non-Alcoholic Fatty Liver Disease

    Article • September 2011, IntechOpen

    Professor Ludovico Abenavoli

  217. Insulin resistance increases risk of carpal tunnel syndrome: a case-control study

    Article • Journal of the Peripheral Nervous System, September 2011, Wiley

    Professor Ludovico Abenavoli, Carmela Colica

  218. Chronic hepatitis C infection and insulin resistance: two best friends

    Article • Expert Review of Anti-infective Therapy, August 2011, Taylor & Francis

    Professor Ludovico Abenavoli

  219. “. . . and Suddenly a Tree!”

    Article • International Journal of Surgical Pathology, August 2011, SAGE Publications

    Professor Ludovico Abenavoli

  220. Role of silymarin to treat fibrosis development in non-alcoholic fatty liver disease

    Article • Hepatology Research, June 2011, Wiley

    Professor Ludovico Abenavoli

  221. Non-alcoholic fatty liver disease and pharmacological options

    Article • International Journal of Clinical Practice, September 2010, Wiley

    Professor Ludovico Abenavoli

  222. Short-term Therapy with Celecoxib and Lansoprazole Modulates Th1/ Th2 Immune Response in Human Gastric Mucosa

    Article • Helicobacter, September 2010, Wiley

    Professor Ludovico Abenavoli

  223. Milk thistle in liver diseases: past, present, future

    Article • Phytotherapy Research, June 2010, Wiley

    Professor Ludovico Abenavoli

  224. Metformin: A Therapeutic Option for Treating Nonalcoholic Fatty Liver Disease

    Article • Digestive Diseases and Sciences, May 2010, Springer Science + Business Media

    Professor Ludovico Abenavoli

  225. Brain hypoperfusion and neurological symptoms in celiac disease

    Article • Movement Disorders, March 2010, Wiley

    Professor Ludovico Abenavoli

  226. Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study

    Article • International Journal of Obesity, February 2010, Nature

    Professor Ludovico Abenavoli

  227. Nervous system in the gluten syndrome: A close relationship

    Article • Medical Hypotheses, January 2010, Elsevier

    Professor Ludovico Abenavoli

  228. Celiac disease: from gluten to skin

    Article • Expert Review of Clinical Immunology, November 2009, Taylor & Francis

    Professor Ludovico Abenavoli

  229. Behçet’s disease and celiac disease: a rare association or a possible link?

    Article • Rheumatology International, October 2009, Springer Science + Business Media

    Professor Ludovico Abenavoli

  230. Phytotherapeutic approach to alcohol dependence: New old way?

    Article • Phytomedicine, June 2009, Elsevier

    Professor Ludovico Abenavoli

  231. Subclinical Neurological Abnormalities and Gluten-Free Diet

    Article • Journal of the American Dietetic Association, December 2008, Elsevier

    Professor Ludovico Abenavoli

  232. Acute alcohol intoxication

    Article • European Journal of Internal Medicine, December 2008, Elsevier

    Professor Ludovico Abenavoli

  233. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis

    Article • Hepatology, September 2008, Wiley

    Professor Ludovico Abenavoli

  234. State and trait anxiety and depression in patients affected by gastrointestinal diseases: psychometric evaluation of 1641 patients referred to an internal medicine outpatient setting

    Article • International Journal of Clinical Practice, April 2008, Wiley

    Professor Ludovico Abenavoli

  235. Subclinical Neurological Abnormalities in Patients With Celiac Disease: Are They Associated by Brain Hypoperfusion?

    Article • Journal of Pediatric Gastroenterology and Nutrition, April 2008, Wolters Kluwer Health

    Professor Ludovico Abenavoli

  236. Complementary therapies for treating alcoholism

    Article • Fitoterapia, February 2008, Elsevier

    Professor Ludovico Abenavoli

  237. Elastography assessment in patients with chronic HCV infection

    Article • International Journal of Clinical Practice, January 2008, Wiley

    Professor Ludovico Abenavoli

  238. Intestinal Malabsorption and Skin Diseases

    Article • Digestive Diseases, January 2008, Karger Publishers

    Professor Ludovico Abenavoli

  239. Affective and Psychiatric Disorders in Celiac Disease

    Article • Digestive Diseases, January 2008, Karger Publishers

    Professor Ludovico Abenavoli

  240. Probiotics: Which and When?

    Article • Digestive Diseases, January 2008, Karger Publishers

    Professor Ludovico Abenavoli

  241. Metabolic and Nutritional Features in Adult Celiac Patients

    Article • Digestive Diseases, January 2008, Karger Publishers

    Professor Ludovico Abenavoli

  242. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study

    Article • The Lancet, December 2007, Elsevier

    Professor Ludovico Abenavoli

  243. Comparing and combining gamma-hydroxybutyric acid (GHB) and naltrexone in maintaining abstinence from alcohol: An open randomised comparative study

    Article • European Neuropsychopharmacology, December 2007, Elsevier

    Professor Ludovico Abenavoli

  244. Neuroendocrine and Psychological Assessment in a Guinness 10 Days Scuba Dive

    Article • International Journal of Sports Medicine, October 2007, Thieme Publishing Group

    Professor Ludovico Abenavoli

  245. Analysis of the T1288R Mutation of the Wilson Disease ATP7B Gene in Four Generations of a Family: Possible Genotype-Phenotype Correlation with Hepatic Onset

    Article • Digestive Diseases and Sciences, April 2007, Springer Science + Business Media

    Professor Ludovico Abenavoli

  246. Celiac disease and skin: Psoriasis association

    Article • World Journal of Gastroenterology, January 2007, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Ludovico Abenavoli

  247. Relationship Between Ghrelin Levels, Alcohol Craving, and Nutritional Status in Current Alcoholic Patients

    Article • Alcoholism Clinical and Experimental Research, November 2006, Wiley

    Professor Ludovico Abenavoli

  248. Marked Decrease of Serum Ca 125 Levels After Denver Shunt Placement in a Patient With Cirrhosis and Refractory Ascites

    Article • Digestive Diseases and Sciences, August 2006, Springer Science + Business Media

    Professor Ludovico Abenavoli

  249. Complementary medicine for alcohol dependence in Italian services: A mail questionnaire

    Article • Complementary Therapies in Clinical Practice, August 2006, Elsevier

    Professor Ludovico Abenavoli

  250. Primary renal angiosarcoma: A rare malignancy. A case report and review of the literature☆

    Article • Urologic Oncology Seminars and Original Investigations, July 2006, Elsevier

    Professor Ludovico Abenavoli

  251. Genotype–phenotype correlation of the Wilson diseaseATP7B gene

    Article • American Journal of Medical Genetics Part A, April 2006, Wiley

    Professor Ludovico Abenavoli

  252. Baclofen in the Treatment of Alcohol Withdrawal Syndrome: A Comparative Study vs Diazepam

    Article • The American Journal of Medicine, March 2006, Elsevier

    Professor Ludovico Abenavoli

  253. A New Mutation of Wilson's Disease P-Type ATPase Gene in a Patient with Cirrhosis and Coombs-Positive Hemolytic Anemia

    Article • Digestive Diseases and Sciences, January 2006, Springer Science + Business Media

    Professor Ludovico Abenavoli

  254. Neurobiochemical and clinical aspects of craving in alcohol addiction: A review

    Article • Addictive Behaviors, July 2005, Elsevier

    Professor Ludovico Abenavoli

  255. CELIAC DISEASE AND SKIN DISORDERS

    Article • Pediatric Dermatology, July 2005, Wiley

    Professor Ludovico Abenavoli

  256. Psychological Support Counseling: A New Strategy to Increase Gluten-Free Diet Compliance in Celiac Patients

    Article • The American Journal of Gastroenterology, June 2005, Nature

    Professor Ludovico Abenavoli

  257. Association between psoriasis and coeliac disease

    Article • British Journal of Dermatology, June 2005, Wiley

    Professor Ludovico Abenavoli

  258. Suppression of Craving for ??-Hydroxybutyric Acid by Naltrexone Administration

    Article • Clinical Neuropharmacology, March 2005, Wolters Kluwer Health

    Professor Ludovico Abenavoli

  259. Gamma hydroxybutyrric acid (GHB) withdrawal does not occur at therapeutic dosage

    Article • Drug and Alcohol Dependence, February 2005, Elsevier

    Professor Ludovico Abenavoli

  260. How Many Cravings? Pharmacological Aspects of Craving Treatment in Alcohol Addiction: A Review

    Article • Neuropsychobiology, January 2005, Karger Publishers

    Professor Ludovico Abenavoli

  261. Neurologic Disorders in Patients With Celiac Disease: Are They Mediated by Brain Perfusion Changes?

    Article • PEDIATRICS, December 2004, American Academy of Pediatrics (AAP)

    Professor Ludovico Abenavoli

  262. Tolerance to baclofen?s sedative effect in alcohol-addicted patients: no dissipation after a period of abstinence

    Article • Psychopharmacology, September 2004, Springer Science + Business Media

    Professor Ludovico Abenavoli

  263. Psychological support counselling improves gluten-free diet compliance in coeliac patients with affective disorders

    Article • Alimentary Pharmacology & Therapeutics, September 2004, Wiley

    Professor Ludovico Abenavoli

  264. Gluten-related cerebral hypoperfusion and neurologic disorders in coeliac patients

    Article • Alimentary Pharmacology & Therapeutics, September 2004, Wiley

    Professor Ludovico Abenavoli

  265. Suppression of Alcohol Delirium Tremens by Baclofen Administration: A Case Report

    Article • Clinical Neuropharmacology, September 2003, Wolters Kluwer Health

    Professor Ludovico Abenavoli

  266. Rapid Regression of Psoriasis in a Coeliac Patient after Gluten-Free Diet

    Article • Digestion, January 2003, Karger Publishers

    Professor Ludovico Abenavoli

  267. Baclofen: clinical data

    Article • Springer Science + Business Media

    Professor Ludovico Abenavoli